LGR5 and colorectal cancer: According to a recent report, Bandara and colleagues developed a panel of six different LGR5-redirected CAR-T products and demonstrated that four of these products were capable of mediating meaningful tumoricidal effects in vitro against cell lines of colorectal cancer (64).